
In an exclusive Q&A at Asembia’s AXS26 Summit, Syneos Health's vice president of strategic market access and patient support Kim Plesnarski touches on rapid digital innovation, evolving market structures, and shifting regulatory pressures.
Kim Plesnarski is an executive leader with more than 20 years of commercial experience in the biopharmaceutical industry, specializing in market access and patient services. She is recognized as a subject matter expert in field reimbursement and patient engagement, with a track record of designing and delivering strategies that support manufacturer partnerships and optimize brand performance. Her expertise spans program development and execution, with a strong foundation in payer dynamics, healthcare provider behavior, and commercial strategy.
In her leadership roles, Plesnarski has focused on building and scaling high-performing teams, overseeing integrated functions including operations, strategy, analytics, training, and customer engagement. She is known for her emphasis on talent development, having cultivated one of the industry’s largest networks of field reimbursement and patient support professionals, with a strong track record of internal promotion and team retention.

In an exclusive Q&A at Asembia’s AXS26 Summit, Syneos Health's vice president of strategic market access and patient support Kim Plesnarski touches on rapid digital innovation, evolving market structures, and shifting regulatory pressures.

In the final part of her interview, Plesnarski notes how market access strategies evolve into core launch drivers as IRA timelines, pricing pressures, and digital adherence tools reshape how companies maximize value.

In this exclusive video interview at Assembia 2026, Kim Plesnarski touches on how digital tools reshape patient access programs as real-time data and EMR integration drive more personalized, workflow-embedded support strategies.